Social factors, treatment, and survival in early-stage non-small cell lung cancer

被引:142
作者
Greenwald, HP
Polissar, NL
Borgatta, EF
McCorkle, R
Goodman, G
机构
[1] Univ So Calif, Sch Publ Adm, Sacramento, CA USA
[2] Mt Whisper Light Stat Consulting, Seattle, WA USA
[3] Univ Washington, Dept Sociol, Seattle, WA 98195 USA
[4] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA
[5] Swedish Hosp, Tumor Inst, Seattle, WA USA
关键词
D O I
10.2105/AJPH.88.11.1681
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. This study assessed the importance of socioeconomic status, race, and likelihood of receiving surgery in explaining mortality among patients with stage-I non-small cell lung cancer. Methods. Analyses focused on Black and White individuals 75 years of age and younger (n=5189) diagnosed between 1980 and 1982 with stage-I non-small cell lung cancer in Detroit, San Francisco, and Seattle. The main outcome measure was months of survival after diagnosis. Results. Patients in the highest income decile were 45% more likely to receive surgical treatment and 102% more likely to attain 5-year survival than those in the lowest decile. Whites were 20% more likely to undergo surgery than Blacks and 31% more likely to survive 5 years. Multivariate procedures controlling for age and sex confirmed these observations. Conclusions. Socioeconomic status and race appear to independently influence likelihood of survival. Failure to receive surgery explains much excess mortality.
引用
收藏
页码:1681 / 1684
页数:4
相关论文
共 33 条
[21]   INFLUENCE OF SOCIAL CLASS IN SURVIVAL OF CANCER PATIENTS [J].
LINDEN, G .
AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1969, 59 (02) :267-&
[22]   SOCIO-ECONOMIC FACTORS IN PROGNOSIS OF CANCER PATIENTS [J].
LIPWORTH, L ;
ABELIN, T ;
CONNELLY, RR .
JOURNAL OF CHRONIC DISEASES, 1970, 23 (02) :105-&
[23]   BLACK-WHITE DIFFERENCES IN TYPE OF INITIAL BREAST-CANCER-TREATMENT AND IMPLICATIONS FOR SURVIVAL [J].
MCWHORTER, WP ;
MAYER, WJ .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1987, 77 (12) :1515-1517
[24]  
PAGE WF, 1980, CANCER, V45, P1029, DOI 10.1002/1097-0142(19800301)45:5<1029::AID-CNCR2820450533>3.0.CO
[25]  
2-3
[26]  
POLEDNAK AP, 1992, CANCER, V70, P2152, DOI 10.1002/1097-0142(19921015)70:8<2152::AID-CNCR2820700824>3.0.CO
[27]  
2-#
[28]  
RIES LG, 1983, JNCI-J NATL CANCER I, V70, P693
[29]  
SARNA GP, 1985, CANCER TREATMENT, P180
[30]  
SHAMBAUGH E, 1991, J NATL CANCER I, V83, P1369